Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Unitary patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 60 2018 050 994.1 |
96 | EP file number | EAKZ | 18 72 4753.1 |
86 | WO file number | WAKZ | PCT/US2018/030144 |
97 | EP publication number | EPN | 3619208 |
87 | WO publication number | WPN | 2018204236 |
54 | Designation/title | TI | KRISTALLINE FORMEN EINER JAK-INHIBITOR-VERBINDUNG |
51 | IPC main class | ICM (ICMV) | C07D 471/04 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/4523 (2006.01), A61P 11/00 (2006.01), A61P 27/00 (2006.01) |
22 | DE application date | DAT | Apr 30, 2018 |
96 | EP application date | EAT | Apr 30, 2018 |
86 | WO application date | WAT | Apr 30, 2018 |
43 | Date of first publication | OT | Nov 8, 2018 |
| Date of publication of grant | PET | Jun 7, 2023 |
71/73 | Applicant/owner | INH | Theravance Biopharma R&D IP, LLC, South San Francisco, CA 94080, US |
72 | Inventor | IN | DABROS, Marta, Foster City, California 94404, US; THALLADI, Venkat R., Foster City, California 94404, US; NZEREM, Jerry, South San Francisco, California 94080, US; KLEINSCHEK, Melanie A., San Francisco, California 94110, US; CRATER, Glenn D., Raleigh, North Carolina 27612, US |
74 | Representative | VTR | Abel & Imray LLP, Bath BA1 2DA, GB |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201762492571 P May 1, 2017
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Member states EPGÜ | EPGUE | AT, BE, BG, DE, DK, EE, FI, FR, IT, LT, LU, LV, MT, NL, PT, SE, SI |
| Published EP/WO documents | EPWOPN | Original document:
EP000003619208A1 Searchable text:
EP000003619208A1 Original document:
EP000003619208B1 Searchable text:
EP000003619208B1 Original document:
WO002018204236 Searchable text:
WO002018204236 |
43 | Date of first publication | EVT | Nov 8, 2018 |
| Date of the first transfer into DPMAregister | EREGT | Mar 11, 2020 |
| Date of the (most recent) update in DPMAregister | REGT | Jun 6, 2025 (Show all update days)(Hide all update days)- Jun 6, 2025
- Type of IP right: changed
- File number displayed in the result list: changed
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 07.06.2023: new
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 07.06.2023: deleted
- Feb 13, 2025
- Status: changed
- Procedures: Administrative procedure, EP patent – unitary effect lapsed, 30.04.2024: new
- Nov 27, 2024
- St.36: changed (technical change)
- Mar 11, 2020
- Date of the first transfer into DPMAregister
|